Study of the Safety and Leukostimulatory Activity of the Preparation "Panagen" in Patients With Breast Cancer
Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
The goal of this trial is to assess the safety, therapeutic dose, and leukostimulatory
activity of the preparation Panagen in the therapeutic schemes for treating cancer diseases
in the patients receiving a standard chemotherapy for breast cancer of stages II-IV (with
distant metastases).